Asset 2 Conferences

Tumor Heterogeneity, Plasticity and Therapy (virtual edition)

5-6 May 2021, Virtual edition
Tumor Heterogeneity, Plasticity and Therapy - campaign visual
Jubileumzaal - Venue picture
Jubileumzaal - Venue picture
Martelaren Square - Leuven (Copyright Tobias - Cornille)
Martelaren Square - Leuven (Copyright Tobias - Cornille)
Old Market - Leuven
Old Market - Leuven
Conference dinner - Faculty Club
Conference dinner - Faculty Club
Grote Markt - Leuven
Grote Markt - Leuven
Totem by Jan Fabre - Leuven
Totem by Jan Fabre - Leuven
Sponsor booths - Leuven
Sponsor booths - Leuven
Poster session - Ghent
Poster session - Ghent

Tumor Heterogeneity, Plasticity and Therapy (virtual edition)

Tumor Heterogeneity, Plasticity and Therapy (virtual edition)
Keep me postedAdd to calendar

We are pleased to announce the first edition of the VIB Conference ‘Tumor heterogeneity, plasticity and therapy’. This will be a virtual conference.

Tumors are complex and evolving ecosystems composed of a wide variety of cell types, in addition to the cancer cells themselves. Increasing evidence indicates that the bi-directional interplay between tumor cells and their tumor microenvironment shape tumor evolution and therapy resistance.

Within a tumor, many cancer cells differ from each at the (epi-)genomic, transcriptional and proteomic level, as well as phenotypically and functionally. Tumor heterogeneity represents a major hurdle for therapy, which may only target a subset of tumor cells. In addition, cancer cell plasticity permits rapidly adaption to therapeutics and development of tolerance and resistance, presenting additional challenges for both targeted and immunotherapies.

During this conference a range of world leaders from academia and industry will discuss the latest developments in basic research, translational and clinical research and therapeutic avenues, in the following sessions:

  • Plasticity in initiation, progression and metastasis
  • Heterogeneity and reprogramming of the tumor immune- and microenvironment
  • Adaptation and resistance to targeted therapies
  • Adaptation and resistance to immunotherapies

Information for abstract submissions:
The deadline for the abstracts submission is 12 March. The best poster will win the Nature Poster Prize.
Important note: If you've submitted an abstract for the original dates of this event (14-15 May 2020) you need to submit your abstract again. Previous submissions for the original dates will not be selected.

Share

Confirmed speakers

Johanna Joyce
Joyce Johanna - profile picture
Johanna Joyce

Johanna Joyce

Department of Oncology, University of Lausanne, Ludwig Institute for Cancer Research, CH
Erika Pearce
Pearce Erika - profile picture
Erika Pearce

Erika Pearce

Johns Hopkins University & Bloomberg-Kimmel Institute for Cancer Immunotherapy, US
Leila Akkari
Akkari Leila - profile picture
Leila Akkari

Leila Akkari

Division of Tumor Biology & Immunology, Oncode Institute. Netherlands Cancer Institute (NKI), NL
Mark Dawson
Dawson Mark - profile picture
Mark Dawson

Mark Dawson

Sir Peter MacCallum Department of Oncology & Centre for Cancer Research, University of Melbourne, AU
Zemin Zhang
Zhang Zemin - profile picture
Zemin Zhang

Zemin Zhang

BIOPIC, College of Life Sciences, and Beijing Advanced Innovation Center for Genomics, Peking University, CN

Program

Day 1 - Wednesday, 05 May, 2021

11:00
12:00
Welcome coffee
12:00
12:10
Welcome
Session 1 - Plasticity & initiation/progression and metastasis (including CTCs)
12:10
12:40
SCLC and vasculogenic mimicry - a route to metastasis?

Caroline Dive

CRUK Manchester Institute, The University of Manchester, UK
12:40
13:10
Dissecting the metastatic microenvironment
13:10
13:20

Presenter to be announced

Selected from abstracts
13:20
13:50
Metastasis metabolism - You are what you eat
13:50
14:20
Targeting Regenerative Plasticity in Metastasis
14:20
14:50
Meet the speaker session 1
14:20
14:50
Coffee Break and Networking
14:50
16:00
Virtual Poster Session 1
Session 2 - Heterogeneity and reprogramming of the Tumor (immune) microenvironment
16:00
16:30
Immune contexture and tumor evolution in the era of immunotherapy

Jerome Galon

INSERM & Laboratory of Integrative Cancer Immunology, Sorbonne Universite, FR
16:30
17:00
Exploring and Exploiting the Tumor Microenvironment

Johanna Joyce

Department of Oncology, University of Lausanne, Ludwig Institute for Cancer Research, CH
17:00
17:10

Presenter to be announced

Selected from abstracts
17:10
17:20
Short break
17:20
17:50
Neuronal activity promotes the progression of glial malignancies
17:50
18:20
Dynamic Properties of Tumor-Infiltrating Immune Cells Revealed by Single Cell Sequencing

Zemin Zhang

BIOPIC, College of Life Sciences, and Beijing Advanced Innovation Center for Genomics, Peking University, CN
18:20
18:50
Closing talk
Epigenetic influence of our (fatty) diet on metastatic-initiating cells
18:50
19:20
Meet the speaker session 2
19:20
20:20
Networking

Day 2 - Thursday, 06 May, 2021

08:45
09:15
Welcome coffee
Session 4 - Adaptation and Resistance to immuno-therapies (including influence of microbiome)
12:10
12:40
Chromosomal instability and genome plasticity in cancer evolution, immune evasion and metastasis
12:40
13:10
Targeting the epigenome in cancer

Mark Dawson

Sir Peter MacCallum Department of Oncology & Centre for Cancer Research, University of Melbourne, AU
13:10
13:20

Presenter to be announced

Selected from abstracts
13:20
13:50
Primary and secondary resistance to cancer immunotherapy
13:50
14:20
Harnessing the potential of myeloid cells in brain and liver cancer treatment: a matter of genetics, time and combination

Leila Akkari

Division of Tumor Biology & Immunology, Oncode Institute. Netherlands Cancer Institute (NKI), NL
14:20
14:50
Meet the speaker session 3
14:20
14:50
Coffee Break and Networking
14:50
16:00
Virtual Poster Session 2
Session 3 - Adaptation and Resistance to targeted therapies
16:00
16:30
Understanding the molecular evolution of tumors during therapy
16:30
17:00
Starvation and pseudo-starvation as drivers of phenotypic plasticity

Colin Goding

Ludwig Institute for Cancer Research, University of Oxford, UK
17:00
17:10

Presenter to be announced

Selected from abstracts
17:10
17:20
Short break
17:20
17:50
Tumor cell plasticity as a challenge for targeted therapies in colorectal cancer
17:50
18:20
Heterogeneity and plasticity in head and neck cancer
Closing Talk
18:20
18:50
Ordering Chaos: Delineating The Cell-Intrinsic Metabolic Signals That Direct Cell Differentiation

Erika Pearce

Johns Hopkins University & Bloomberg-Kimmel Institute for Cancer Immunotherapy, US
18:50
19:00
Closing remarks
19:00
19:30
Meet the speaker session 4

Organizing committee

Abstracts

Submit your abstract for this event

Register before the early bird deadline if you would like your abstract to be recorded in the program book.

Abstract submission closing date:   Friday, 12 March, 2021
Submit an abstract
The full list of abstracts will be available on 26-04-2021 until 20-05-2021
This list will only be available for registered attendees of the event.

Attendees

The full list of attendees will be available on 26-04-2021 until 20-05-2021
This list will only be available for registered attendees of the event.

Buy tickets for this event

Other available tickets

PhD student ticket - virtual
PhD student
€100.00 excl. VAT
 
Academic ticket - virtual
Academic
€125.00 excl. VAT
 
Industry ticket - virtual
Industry
€175.00 excl. VAT